Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mecapegfilgrastim vs rhG-CSF in lymphoma post-ASCT
NCT05156554Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Dec 2021
- Primary completion
- Dec 2022
- Modality
- rProtein (Recombinant Protein), Biologic
01
Overview
Randomised, open-label trial of mecapegfilgrastim in neutropenia (2 arms), sponsored by Sun Yat-sen University. Primary endpoint: Time to neutrophil engraftment at 30 days. Status: unknown.
02
Drugs
mecapegfilgrastim
03
Conditions
neutropenia
Beyond the preview
Go deeper on NCT05156554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05156554.